The $900bn fiscal relief deal agreed by Congress won’t represent as big a fiscal expansion as the headline figures suggest as it appears to mostly involve recycling the unused funding from previous stimulus deals this year. Nevertheless, it provides another reason to expect GDP growth to rebound markedly next year as vaccines are rolled out.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.